We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Galapagos Obtains U.S. Patent Protecting Its Discovery Platform

This patent protects the method of determining the function of a nucleic acid.
News

Diosynth Announces Agreement with ImmunoGen

Diosynth will manufacture bulk huN901 antibody for ImmunoGen.
News

Kreido’s STT® Reactor System to Be Utilized by Huntsman

The STT® system improves selectivity, increase yields and initiate chemistries.
News

Rib-X Granted Key Antibiotic Drug Discovery Patents

The patents describe Rib-X's position on crystal structures of the 50S subunit of the ribosome.
News

Dharmacon Establishes Genome-Wide RNAi Global Initiative with Research Institutes

The goal of the Global Initiative is to accelerate the scientific and medical discoveries.
News

Aureus Licenses AurSCOPE® GPCR to Euroscreen

Euroscreen will use Aureus Pharma's technology to identify GPCR drug candidates.
News

Astellas and MerLion Announce Drug Discovery Agreement

MerLion will utilise Astellas' extensive natural sample collection and modern high throughput screening facilities.
News

NIH Grantees Win 2005 Nobel Prize in Chemistry

The Prize is shared by two NIH grantees, Robert H. Grubbs, Ph.D. and Richard R. Schrock, Ph.D., along with Yves Chauvin, Ph.D.
News

Caliper Completes Acquisition of NovaScreen

The acquisition combines NovaScreen's screening, profiling and assay development services with Caliper's LabChip® and liquid handling products.
News

Publication Shows Potential of Therapeutic Gene Silencing

The research, published in Cancer Research, represents a significant advance in the development of systemic RNAi therapeutics.
Advertisement